apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients (2017) Gross S, Erdmann M, Haendle I, Voland S, Berger T, Schultz E, Strasser E, et al. Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2017) Boßerhoff AK, Schuler G, Heinzerling L, Schilling B, Haferrkamp S, Kirchberger M Conference contribution, Conference Contribution Fear of progression in patients with low-risk malignant melanoma (2017) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Conference contribution BRAF and MEK inhibitors influence human immune cell phenotype and function (2017) Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al. Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution Eosinophilic count as a biomarker for prognosis of melanoma patients (2017) Moreira A, Heinzerling L Conference contribution Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients (2017) Cosgarea , Zimmer L, Weide B, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, et al. Conference contribution Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP) (2017) Offenmüller S, Leiter U, Bernbeck B, Garbe C, Eigentler T, Borkhardt A, Classen CF, et al. Journal article Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy (2017) Moreira A, Leisgang W, Schuler G, Heinzerling L Journal article